The world pharmaceutical market is practically divided in two, says the professor of international health policy at the University of Tampere Meri Koivusalo. To rich countries, where pharmaceutical production chains and sales are closely monitored, and to poor countries, where pharmaceutical market regulation is often non-existent.
Toxic drugs are suspected to have killed more than 200 children – the case is only the tip of the iceberg of a phenomenon that is considered a silent epidemic
